People · Operator
Named in public records as an officer, director or promoter · active 2011–2024 · Pharma, Investment Vehicle, Healthtech, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Averna Therapeutics Inc. | — | Pharma | Series C | $85.0M | $805.0M | 2024 |
| AIU Alternative Care Oz Fund LP | — | Investment Vehicle | Series A | $5.5M | $82.8M | 2019 |
| AIU Alternative Care, Inc. | — | Healthtech | Seed | $2.6M | $70.8M | 2019 |
| Tresata, Inc. | — | Other Technology | Pre-Seed | $1.3M | $31.8M | 2011 |
Richard Morris at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Richard Morris on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| James Walesa | 2 | 4 |
| Randall Hawkins | 2 | 3 |
| Dickson Co | 2 | 3 |
| B.J. Parrish | 2 | 2 |
| Dylan Morris | 1 | 8 |
| Stephen Squinto | 1 | 8 |
| Henry Chen | 1 | 7 |
| Michal Silverberg | 1 | 7 |
| Tal Zaks | 1 | 3 |
| Nick Olsen | 1 | 2 |
| Abhishek Mehta | 1 | 1 |
| Richard L. Prager | 1 | 1 |
| Thomas Barnes | 1 | 1 |
| Roy Amariglio | 1 | 1 |
| Raju Prasad | 1 | 1 |
| Tal Zaks, M.D., Ph.D. | 1 | 1 |
| Raju Prasad, Ph.D. | 1 | 1 |
| Thomas Barnes, Ph.D. | 1 | 1 |
| Aaron Nelson | 1 | 1 |
| Anat Nursella | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.